Does Rallies show 13F holders for CMMB?

Yes. Rallies tracks hedge fund and 13F ownership data for CMMB, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CMMB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CMMB. It does not provide personalized investment advice.

CMMB (Chemomab Therapeutics Ltd. American Depositary Share) Stock Analysis - Hedge Fund Holdings

Chemomab Therapeutics Ltd. American Depositary Share (CMMB) is a publicly traded Healthcare sector company. As of May 21, 2026, CMMB trades at $1.75 with a market cap of $11.66M and a P/E ratio of 13.47. CMMB moved +5.81% today. Year to date, CMMB is -11.23%; over the trailing twelve months it is -70.14%. Its 52-week range spans $1.35 to $9.84. Analyst consensus is buy with an average price target of $15.00. Rallies surfaces CMMB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CMMB stock?

Hedge funds tracked by Rallies that own CMMB include Orbimed Advisors. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Chemomab Therapeutics Ltd. American Depositary Share.

CMMB Key Metrics

Key financial metrics for CMMB
Metric	Value
Price	$1.75
Market Cap	$11.66M
P/E Ratio	13.47
EPS	$0.12
Dividend Yield	0.00%
52-Week High	$9.84
52-Week Low	$1.35
Volume	79
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-27.65M
Gross Margin	0.00%

Top Hedge Funds Holding CMMB

Orbimed Advisors holds 940.99K shares of CMMB, changed -45.96% as of Jun 30, 2025.

Latest CMMB News

Three EASL Studies Show Nebokitug Lowers Fibrosis Scores and IBD Markers — May 14, 2026

Recent CMMB Insider Trades

OrbiMed Israel GP Ltd. sold 266.38K (~$889.70K) on Jan 3, 2023.
OrbiMed Israel GP Ltd. sold 70.52K (~$318.06K) on Jan 3, 2023.
Mor George Adi sold 7.70K (~$38.71K) on Jan 3, 2023.

CMMB Analyst Consensus

2 analysts cover CMMB: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.00.

Common questions about CMMB

Who owns CMMB stock?: Hedge funds tracked by Rallies that own CMMB include Orbimed Advisors. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Chemomab Therapeutics Ltd. American Depositary Share.
Does Rallies show 13F holders for CMMB?: Yes. Rallies tracks hedge fund and 13F ownership data for CMMB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CMMB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CMMB. It does not provide personalized investment advice.